UCB Pharma (VOGALENE And VOGALIB) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

UCB Pharma (VOGALENE And VOGALIB) General Information

Description

Two medicinal products. The portfolio comprises of development, manufacturing, marketing and sale of Vogalib(R) and Vogalene(R) medicines. They are approved for use in the symptomatic treatment of nausea and vomiting. The injectible is approved for the prevention of nausea and vomiting in patients under chemotherapy.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Biotechnology
Acquirer
Primary Office
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

UCB Pharma (VOGALENE And VOGALIB) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore UCB Pharma (VOGALENE And VOGALIB)‘s full profile, request access.

Request a free trial

UCB Pharma (VOGALENE And VOGALIB) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore UCB Pharma (VOGALENE And VOGALIB)‘s full profile, request access.

Request a free trial